We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Biotricity Inc (BTCY) USD0.001

Sell:$1.20 Buy:$1.21 Change: $0.13 (9.40%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.13 (9.40%)
Prices delayed by at least 15 minutes | Switch to live prices |
Change: $0.13 (9.40%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Biotricity Inc. is a medical technology company, which is focused on biometric data monitoring solutions. The Company developed its Bioflux MCT technology, comprised of a monitoring device and an ECG reporting software component. The Bioflux device is comprised of a wet electrode and worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patient’s electrocardiogram (ECG) data for monitoring and diagnostic purposes. Both the device and software are in accordance with mobile cardiac telemetry (MCT) billing code standards, compliant with arrhythmia devices and alarms, and require 510000 clearance, which has been obtained. The Bioflux device has been developed, among other things, with global system for mobile communications (GSM) mobile chip for global cellular network compatibility; touch-screen liquid crystal display (LCD) viewer; and extended battery pack for an additional approximately 48 hours of battery life.

Contact details

203 Redwood Parkway, Suite 600
United States
+1 (650) 8321626

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$55.92 million
Shares in issue:
51.28 million
Health Care Technology
United States
US dollar

Key personnel

  • Waqaas Al-Siddiq
    Founder, Chairman, Chief Executive Officer and Executive Officer
  • John Ayanoglou
    Chief Financial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.